Baird raised the firm’s price target on Intuitive Surgical (ISRG) to $610 from $575 and keeps an Outperform rating on the shares. The firm updated its model following beat and raise Q1 results but caution MedTech may overshadow.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target lowered to $580 from $620 at Piper Sandler
- Intuitive Surgical: Strong Operating Momentum and Global Adoption Tailwinds Justify Buy Rating Despite Elevated Valuation
- Closing Bell Movers: Capital One, Interactive Brokers slip after results
- Intuitive Surgical says lower growth rate reflects ongoing China/Japan challenge
- Intuitive Surgical names new Chief Medical Officer